| 溶解性 | DMSO 105 mg/mL Water 1 mg/mL Ethanol <1 mg/mL |
| 存贮条件 | 储存温度-20°C |
| 备注 | ENMD-2076 has selective activity against Aurora A and VEGFR(Flt3) with IC50 of 14 nM and 1.86 nM, 25-fold selective for Aurora A than over Aurora B and less potent to VEGFR2/KDR and VEGFR3, FGFR1 and FGFR2 and PDGFRα. Phase 2. |
| 生化机理 | ENMD-2076 is a antiangiogenic and Aurora kinase inhibitor with IC50 of 3, 13, 350, 23, 40, 93 and 120 nM for Flt-3, AurA, AurB, Src, KDR/VEGFR2 and FGFR1. |
| 别名 | (E)-N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine;(E)-N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine |
ENMD-2076
6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amine （订货以英文为准）
编号：E126318
CAS号：934353-76-1
分子式：C21H25N7.C4H6O6
分子量：525.56
| 产品名称 | 6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amine |
| 中文名称 | ENMD-2076 |
| CAS号 | 934353-76-1 |
| 分子式（M.F.） | C21H25N7.C4H6O6 |
| 分子量（M.W.） | 525.56 |
| 储存条件 | -20°C储存 |
| 标识符号 | https://www.aladdin-e.com/images/ghs/ghs07.jpg |
| 信号词 | Warning |
| 危害声明 | H315-H319-H335 |
| 警示性声明 | P261-P305 + P351 + P338 |
| WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 5212.00
2106-0016-1箱
¥ 3406.00
2106-0002 -1箱
¥ 3289.00
2106-0001-1箱
¥ 510.00
P9157-50T-PKG-5T
党沛 
